Aspirin www.bayer.com
  Search Sitemap
General Conditions of Use
Privacy Statement
Imprint
Copyright
 
The Event
ESC2008_as_3525-1-big.jpg More than 30,000 visitors from all parts of the globe gathered in Munich for this year’s ESC (European Society of Cardiology) Congress in Munich (Aug. 30 – Sept. 3), one of the most important cardiology Congress in the world. And of course, Bayer Schering Pharma (BSP) - a founding father of the conference and major sponsor - was more than represented. With a total of six satellite symposia, plus many other activities, as well, BSP General Medicine was able to spread the word regarding its longstanding experience and competence in Cardiovascular Risk Management (CVRM) and the effectiveness of both its new and mature products.

Delegates roaming the hall could stop at the 300 sqm booth space, where CVRM presented Aspirin Cardio (low-dose aspirin), Adalat (nifedipine GITS), Pritor/Kinzal (telmisartan) and Glucobay (acarbose) under the strategic motto 'Connecting Cardiovascular Prevention Strategies.' Such tools as a CVRM screen animation, an eLearning game and a code breaker quiz illustrated perfectly the CVRM strategy, the coexisting and overlapping CV risk factors in many patients -- e.g., hypertension, diabetes and established CVD -- and how optimal treatment should offer benefits for comprehensive risk factor management, as the CVRM products do. Other brands represented at the booth included Ventavis (iloprost) and, since diagnostic imaging was the official topic at the Congress, there was also information on Diagnostic Imaging with Ultravist and Vasovist. And a matter of fact, the concept of 'connecting' was taken literally since the booth was connected to a 150sqm Xarelto booth, which was similar in both style and concept and highlighted and rounded off the impressing presence of BSP at the ESC.
home_home_testimonial.jpg
"After five years the external data monitoring board asked that we terminate the study because of a striking, very extreme benefit of aspirin. Aspirin® reduced the risk of a first heart attack by 44 percent, and this was quite an earthshaking finding at that time."
Relaxing Screensaver
Aspirin Cardio® Screensaver
Out now: The new Aspirin Cardio® Screensaver.
Download here...
home_home_testimonial_trailer.jpg
Aspirin Cardio® Trailer
Click here to download the Aspirin Cardio® Trailer "Did you know..."